Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$16,204,300
+$3,756,133 QoQ
Shares Held
13,510
-0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#998
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAILARD, INC. holds $201,504,836 across 13 Drug Manufacturers - General names. LLY ranks #4 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
734,610 | $92,810,627 | |
| 2 | JNJ |
Johnson & Johnson
|
147,802 | $37,537,273 | |
| 3 | AMGN |
Amgen Inc
|
49,586 | $17,956,082 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
13,510 | $16,204,300 | |
| 5 | ABBV |
AbbVie Inc.
|
55,207 | $13,892,289 | |
| 6 | AZN |
Astrazeneca PLC
|
70,691 | $13,404,427 | |
| 7 | MRK |
Merck & Co., Inc.
|
26,669 | $3,426,966 | |
| 8 | NVS |
Novartis AG
|
13,869 | $2,173,549 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,204,300 | 13,510 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $12,448,167 | 13,534 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $13,725,814 | 12,772 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $10,228,778 | 13,406 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $10,126,094 | 12,990 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $10,792,165 | 13,067 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $10,070,740 | 13,045 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,916,326 | 11,193 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $11,857,761 | 13,097 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $9,764,175 | 12,551 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $7,570,382 | 12,987 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $6,666,320 | 12,411 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $6,632,315 | 14,142 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,551,306 | 10,341 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $3,832,174 | 10,475 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $3,421,043 | 10,580 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $3,227,061 | 9,953 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,187,294 | 7,638 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,370,796 | 8,583 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,986,567 | 8,598 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,880,686 | 8,194 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,496,988 | 8,013 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $997,844 | 5,910 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $975,451 | 6,590 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,034,662 | 6,302 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $408,530 | 2,945 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||